Aisling Capital Management

Aisling Capital Management as of March 31, 2024

Portfolio Holdings for Aisling Capital Management

Aisling Capital Management holds 16 positions in its portfolio as reported in the March 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Bridgebio Pharma (BBIO) 63.5 $188M 6.1M 30.92
Syndax Pharmaceuticals (SNDX) 8.3 $24M 1.0M 23.80
Verona Pharma Sponsored Ads (VRNA) 6.1 $18M 1.1M 16.09
Elevation Oncology (ELEV) 4.9 $15M 2.8M 5.13
Biomea Fusion (BMEA) 4.0 $12M 799k 14.95
Monte Rosa Therapeutics (GLUE) 3.5 $10M 1.5M 7.05
Nuvation Bio Com Cl A (NUVB) 3.1 $9.2M 2.5M 3.64
Compass Pathways Sponsored Ads (CMPS) 2.7 $8.0M 965k 8.32
Poseida Therapeutics I (PSTX) 1.1 $3.3M 1.0M 3.19
Calcimedica (CALC) 0.7 $2.2M 521k 4.16
Reneo Pharmaceuticals (RPHM) 0.5 $1.5M 886k 1.66
Marker Therapeutics Com New (MRKR) 0.5 $1.4M 314k 4.30
Avrobio Ord (AVRO) 0.4 $1.3M 1.0M 1.28
Spruce Biosciences (SPRB) 0.3 $948k 1.2M 0.79
Aclaris Therapeutics (ACRS) 0.2 $539k 435k 1.24
Viracta Therapeutics (VIRX) 0.1 $294k 289k 1.02